marketshareAI

Bioventix

BVXPHealthcare
2,700.00GBX
-1.82%
Market Cap
143.64M
Volume
1.33k
14% of avg
P/E Ratio
0.15
EPS (TTM)
179.3
Beta
0.51
Day Range
2,700.00p - 2,800.00p
52 Week Range
2,200.00p2,700.00p4,580.00p
2,700.00p

Upcoming Events

Late Q3 2025
Expected field trials for water quality project
High Impact Event
Early 2026
Anticipated return to growth driven by troponin and Tau revenues
High Impact Event
BVXP
NEUTRAL

Bioventix Director Purchases Shares

The Chief Financial Officer of the biotechnology company has purchased a small number of shares.

BVXP
BAD

Bioventix Raises Funds Through Discounted Share Placement

The healthcare company has announced a discounted equity raise, raising concerns about its financial health and future funding prospects.

BVXP
NEUTRAL

Bioventix Reports Flat Revenue and Lower Profits in Interim Results

The biotechnology firm reported flat revenue and lower profits in its interim results. Increased R&D spending and promising developments in Alzheimer's disease testing antibodies highlight a focus on future growth.

BVXP
NEUTRAL

Bioventix CFO Buys Shares in Routine Transaction

Routine share purchase by Bioventix CFO, unlikely to affect healthcare company's valuation.

BVXP
NEUTRAL

Gresham House Increases Stake in Bioventix

Biotech firm Bioventix sees increase in major shareholder stake

BVXP
NEUTRAL

Bioventix CFO Adds to Shareholding

Routine director purchase in UK biotech firm

BVXP
NEUTRAL

Bioventix Announces Annual Report and AGM Notice

Routine regulatory update from a niche biotechnology company

BVXP
NEUTRAL

Bioventix Announces Director Share Purchase

The healthcare company announced its Chief Financial Officer purchased a small number of shares, a routine regulatory disclosure with no apparent material impact.

BVXP
GOOD

Bioventix Reports 6% Revenue Growth in 2024 Annual Results

The biotechnology firm reported a 6% revenue increase and 5% profit growth, with promising developments in Alzheimer's diagnostics and expansion in the Chinese market, despite challenges in mature product lines.

BVXP
NEUTRAL

Major Shareholder Reduces Stake in Bioventix

Healthcare company Bioventix sees a major shareholder reduce its stake, potentially impacting sentiment.